Subscribe
 

Eliot works with Science's news staff in Europe and Asia; edits stories on medical research topics in Washington, D.C.; and writes about patents and other science policy issues. As a reporter for Science, he previously covered topics including radiation health risks, space policy, bioethics, and genome sequencing. Before joining Science, he wrote about politics, health care, and energy for The New Republic in Washington.

More from Author

  • 14 Mar 2000

    It's not often that heads of state wade into a furious quarrel in the scientific community, but both President Clinton and British Prime Minister Tony Blair did so this week.

  • 7 Mar 2000

    Any hope for a collaboration between genome scientists at commercial and nonprofit labs dissolved this week in bitter arguments over who would control the raw data.

  • 23 Feb 2000

    Academic scientists are stewing about a recently issued patent that gives a private company the rights to CCR5, a human gene that plays a key role in HIV infection. The company, Human Genome Sciences Inc.

  • 18 Feb 2000

    WASHINGTON, D.C.--Doctors have known for decades about a rare metabolic disorder that boosts blood levels of an amino acid called homocysteine, causing mental retardation in severely affected children and early cardiovascular problems in others.

  • 8 Feb 2000

    WASHINGTON, D.C.--President Clinton, warning that "the fear of misuse of private genetic information is ...

  • 7 Feb 2000

    The Administration's proposed 2001 budget for the National Institutes of Health (NIH) is receiving less than a standing ovation from biomedical lobbyists.

  • 21 Jan 2000

    A new agreement cuts away some of the red tape snarling cancer research. The policy, announced by the National Institutes of Health (NIH) on 19 January, allows NIH-funded scientists doing noncommercial research to use patented transgenic animals without the written approval of the E.I.

  • 20 Jan 2000

    WASHINGTON, D.C.--Scientists who also practice medicine are becoming an "endangered species," a group of bench researchers said yesterday.

  • 11 Jan 2000

    A new name tops the list of potential future directors of the National Institutes of Health (NIH).

  • 21 Dec 1999

    WASHINGTON, D.C.--Led by three institute chiefs, a band called "The Directors" performed last week at a send-off for outgoing NIH boss Harold Varmus, who's about to head off to Memorial Sloan-Kettering in New York City.

Pages